Ragnar Linder

All filings by Ragnar Linder on record concern AlzeCure Pharma AB. The record holds 4 filings, for trades running from 27 May 2020 to 23 December 2022.

Every open-market trade on record is a purchase: 3 purchases worth €13k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

Half of the purchases are above €5,295 and half below. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 26 December 2022, the filings show a transaction worth €2,398 in AlzeCure Pharma AB. The last insider purchase was made public on 8 June 2020, 2,345 days ago. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.